Recent evidence from Nature Reviews Disease Primers identifies three critical clinical insights that should reshape how practitioners approach chronic graft-versus-host disease management. First, systematic multi-organ screening protocols are non-negotiable components of post-transplant surveillance, with skin, oral, gastrointestinal, hepatic, and pulmonary systems requiring regular assessment. Second, the disease pathophysiology involves both immune activation and fibrotic remodeling processes, necessitating nuanced therapeutic approaches rather than immunosuppression alone. Third, and often overlooked, the quality-of-life impacts of chronic graft-versus-host disease extend far beyond measurable organ dysfunction—functional disability, psychosocial burden, and mental health consequences are substantial. Modern clinical management therefore demands integrated multidisciplinary teams that address not only tissue damage but also the emotional and social dimensions of chronic disease. Patient-centered approaches that incorporate psychological support significantly improve long-term outcomes and recovery trajectories. Read the full article on GMJ Newsroom.
Was this article helpful?
